Physician profile
Michael J Bashline
NPI 1134581143
$23,264.65
in general payments reported to CMS, 2019-2025
32 companies · $3,503 in 2025
The $3,503 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2021: $155 · 2022: $3,927 · 2023: $11K · 2024: $4,644 · 2025: $3,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,656 · Grant: $6,250 · Travel and Lodging: $5,112 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,655.52 |
| Grant | $6,250.00 |
| Travel and Lodging | $5,112.01 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,377.97 | 2022-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $4,608.80 | 2019-2025 | General - Vascular Intervention, Avvigo Guidance System, Angiojet Ultra 5000a |
| Abbott Laboratories | $3,473.91 | 2022-2025 | Navitor, Mitraclip, Diamondback Coronary |
| Edwards Lifesciences Corporation | $2,115.08 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $661.70 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $581.13 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $502.70 | 2022-2023 | Diamondback Coronary |
| Abiomed | $463.30 | 2023-2025 | Impella |
| W. L. Gore & Associates, INC. | $287.46 | 2022-2024 | Gore Cardioform Septal Occluder |
| Terumo Medical Corporation | $285.08 | 2024 | Glidesheath Slender, Optitorque, Metacross Otw |
| Stryker Corporation | $281.78 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $273.77 | 2022-2025 | Farxiga |
| Teleflex LLC | $193.55 | 2023-2025 | Guideliner, Supercross, Twin-Pass |
| Zoll Circulation INC | $172.56 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Novartis Pharmaceuticals Corporation | $121.23 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $112.47 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $108.68 | 2023-2025 | Camzyos, Eliquis |
| Zoll Respicardia, INC. | $99.75 | 2025 | Remede System |
| United Therapeutics Corporation | $81.60 | 2019 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Novo Nordisk INC | $71.70 | 2025 | Ozempic, Wegovy |
| Cardiva Medical, INC. | $59.55 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $47.68 | 2024-2025 | Verquvo |
| Medtronic Vascular, INC. | $33.26 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $25.67 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $24.70 | 2025 | Attruby |
| Angiodynamics, INC. | $23.28 | 2023 | Alphavac |
| Irhythm Technologies, INC. | $20.56 | 2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $20.53 | 2025 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $20.50 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.45 | 2025 | Jardiance |
| Heartflow, INC. | $17.23 | 2023 | Ffrct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bashline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.